Nephros Inc. (NASDAQ:NEPH) Short Interest Update

Nephros Inc. (NASDAQ:NEPH) was the target of a large increase in short interest in the month of January. As of January 30th, there was short interest totaling 9,897 shares, an increase of 32.0% from the January 15th total of 7,496 shares. Based on an average daily trading volume, of 44,093 shares, the short-interest ratio is presently 0.2 days. Currently, 0.1% of the company’s shares are sold short. Currently, 0.1% of the company’s shares are sold short. Based on an average daily trading volume, of 44,093 shares, the short-interest ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Nephros in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Nephros has an average rating of “Moderate Buy” and an average target price of $6.00.

Hedge Funds Weigh In On Nephros

A number of institutional investors and hedge funds have recently modified their holdings of NEPH. Geode Capital Management LLC grew its position in shares of Nephros by 3.2% during the 2nd quarter. Geode Capital Management LLC now owns 93,187 shares of the company’s stock worth $381,000 after buying an additional 2,898 shares during the period. HighTower Advisors LLC boosted its stake in Nephros by 7.2% during the fourth quarter. HighTower Advisors LLC now owns 59,710 shares of the company’s stock worth $291,000 after acquiring an additional 4,000 shares in the last quarter. Citadel Advisors LLC grew its holdings in Nephros by 39.2% in the third quarter. Citadel Advisors LLC now owns 16,545 shares of the company’s stock worth $78,000 after purchasing an additional 4,655 shares during the period. Kestra Advisory Services LLC acquired a new stake in Nephros in the fourth quarter worth $29,000. Finally, Heron Bay Capital Management bought a new stake in Nephros in the fourth quarter valued at $66,000. 41.10% of the stock is currently owned by institutional investors.

Nephros Stock Up 9.0%

NEPH opened at $4.10 on Monday. Nephros has a twelve month low of $1.39 and a twelve month high of $6.42. The company has a fifty day moving average of $4.65 and a 200-day moving average of $4.64. The stock has a market cap of $43.58 million, a PE ratio of 31.54 and a beta of 1.40.

Nephros Company Profile

Nephros, Inc is a development-stage company specializing in advanced water filtration and purification technologies for medical, laboratory, industrial and defense applications. The company’s core offering centers on proprietary hollow fiber ultrafilters designed to remove bacteria, viruses, endotoxins and particulates from water streams. These ultrafilters are used in hemodialysis systems to protect patient treatment, in pharmaceutical and laboratory environments to ensure water quality and in critical field-deployable units for military and emergency response.

The company’s product portfolio includes standalone filtration cartridges for point-of-use and point-of-entry installations in dialysis clinics and hospitals, as well as bench-top and portable water purification systems.